Paxlovid reduces risk of COVID-19 death by 81%, Clalit study shows
So far, over 30,000 COVID-19 patients in Israel have been treated with the anti-viral Paxlovid drug.
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022. (photo credit: REUTERS/ JENNIFER LORENZINI)
